Is SRI 1720 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use SRI 1720? Is SRI 1720 safe for nursing mother and child? Does SRI 1720 extracts into breast milk? Does SRI 1720 has any long term or short term side effects on infants? Can SRI 1720 influence milk supply or can SRI 1720 decrease milk supply in lactating mothers?
SRI 1720 lactation summary
- DrLact safety Score for SRI 1720 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of SRI 1720 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that SRI 1720 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using SRI 1720 .
- Usage of SRI 1720 is in contradiction to breastfeeding hence if it is must to use SRI 1720 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About SRI 1720 usage in lactation
Drug is cleared from the body after 25-50 elimination half-life. Resuming breastfeeding is likely safe after 48 hours of pump-and-dump.
Answer by DrLact: About SRI 1720 usage in lactation
No information is available on the use of SRI 1720 during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, especially alkylating agents such as SRI 1720.[1] The manufacturer recommends that breastfeeding be discontinued during SRI 1720 therapy and for 1 month after the last dose.
SRI 1720 Possible Effects in Breastfeeding
Some evidence indicates that SRI 1720 can increase serum prolactin.[2]